The ultimate goals of the University of Chicago CTSA program are to train scientists and health careproviders at the University, our partner institutions, and our Community to determine the molecularunderpinnings of disease or disease predisposition in any individual patient; to develop, test, implement, andmake readily available to residents in our Community personalized therapies directed toward those individualunderpinnings; and to do this in a way that is rigorous, valid, efficient, ethical, and respectful of ourCommunity's needs and values. In a robust alliance with Argonne National Laboratory, the Illinois Institute ofTechnology, and two large healthcare organizations, we will undertake three bold new steps that willtransform clinical and translational research at our institutions and in our Community: 1) Creation of anInstitute for Translational Medicine, a new University-wide structure to collect, integrate, and disseminate theintellectual, organizational, and resource infrastructure needed to promote and support multidisciplinarytranslational research collaborations; 2) Synergistic research interaction with a new UC Urban HealthInitiative which, through partnership with Community stakeholders, aims to improve Community health careaccess and quality, to build health literacy and trust throughout the Community, to enhance a translationalresearch program informed by and responsive to the needs of the Community, and so to reduce healthdisparities; and 3) Establishment of a new academic Committee on Clinical and Translational Science and ofmultiple novel training programs to encourage and develop careers in clinical and translational research,intended for high school students through university faculty and across the entire translational researchspectrum. Our consortium of dedicated CTSA investigators will employ a systems medicine approach toleverage their particular expertise in social science, genetic medicine, and integrative therapeutics. Together,this team and these transforming innovations will allow the University of Chicago CTSA to prepare the nextgeneration of clinical and translational researchers to realize our vision of widely available, effective, andpersonalized therapies that find everyday application in Community practice and thereby reduce healthdisparities in diverse adult and pediatric populations.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Mccloskey, Donna J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Castelli, Gregory; Friedlander, Mary P (2018) PURL: Time to switch to nonsterile gloves for these procedures? J Fam Pract 67:507-508
Marshall, Bob; Prasad, Shailendra; Noel, Mary A et al. (2018) PURL: First-time, mild diverticulitis: Antibiotics or watchful waiting? J Fam Pract 67:435;436;438
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898
Phelps, Karen; Deavers, Justin; Seehusen, Dean A et al. (2018) PURL: Let low-risk moms eat during labor? J Fam Pract 67:379-380
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Rubin, Daniel S; Matsumoto, Monica M; Weinberg, Guy et al. (2018) Local Anesthetic Systemic Toxicity in Total Joint Arthroplasty: Incidence and Risk Factors in the United States From the National Inpatient Sample 1998-2013. Reg Anesth Pain Med 43:131-137
Hughes, Pamela; Lyon, Corey (2018) PURLs: Tamsulosin for patients with ureteral stones? J Fam Pract 67:37-38
Calway, Tyler; Rubin, Daniel S; Moss, Heather E et al. (2018) Perioperative Retinal Artery Occlusion: Incidence and Risk Factors in Spinal Fusion Surgery From the US National Inpatient Sample 1998-2013. J Neuroophthalmol 38:36-41
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Parker, William F; Anderson, Allen S; Hedeker, Donald et al. (2018) Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates. J Am Coll Cardiol 71:1715-1725

Showing the most recent 10 out of 491 publications